Search Results - "Abbink, Peter"
-
1
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Published in Science (American Association for the Advancement of Science) (14-08-2020)“…An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for vaccine and public health strategies…”
Get full text
Journal Article -
2
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Published in Nature (London) (01-11-2018)“…The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of…”
Get full text
Journal Article -
3
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Published in Science (American Association for the Advancement of Science) (09-09-2016)“…Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a…”
Get full text
Journal Article -
4
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys
Published in Cell (04-05-2017)“…Zika virus (ZIKV) is associated with severe neuropathology in neonates as well as Guillain-Barré syndrome and other neurologic disorders in adults. Prolonged…”
Get full text
Journal Article -
5
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers
Published in Immunity (Cambridge, Mass.) (15-01-2019)“…Passive administration of HIV neutralizing antibodies (nAbs) can protect macaques from hard-to-neutralize (tier 2) chimeric simian-human immunodeficiency virus…”
Get full text
Journal Article -
6
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques
Published in PLoS pathogens (01-08-2017)“…Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera against Zika virus (ZIKV), promoting increased ZIKV infection…”
Get full text
Journal Article -
7
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Published in Cell (24-10-2013)“…The global diversity of HIV-1 represents a critical challenge facing HIV-1 vaccine development. HIV-1 mosaic antigens are bioinformatically optimized…”
Get full text
Journal Article -
8
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Published in Annals of internal medicine (01-05-2021)“…Zika virus (ZIKV) may cause severe congenital disease after maternal-fetal transmission. No vaccine is currently available. To assess the safety and…”
Get full text
Journal Article -
9
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Published in Science translational medicine (13-12-2017)“…An effective Zika virus (ZIKV) vaccine will require long-term durable protection. Several ZIKV vaccine candidates have demonstrated protective efficacy in…”
Get more information
Journal Article -
10
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Published in Nature (London) (02-02-2012)“…Protective efficacy of novel vaccine candidates in rhesus monkeys opens new paths for the development of an HIV-1 vaccine. Vaccines protect against virulent…”
Get full text
Journal Article -
11
Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge
Published in PloS one (24-08-2018)“…In 2015, there was a large outbreak of Zika virus (ZIKV) in Brazil. Despite its relatively mild impact on healthy adults, ZIKV infection during pregnancy has…”
Get full text
Journal Article -
12
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
Published in Nature communications (22-06-2018)“…Zika virus (ZIKV) emerged on a global scale and no licensed vaccine ensures long-lasting anti-ZIKV immunity. Here we report the design and comparative…”
Get full text
Journal Article -
13
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
Published in Nature communications (21-12-2018)“…The precise time when the viral reservoir is seeded during acute HIV-1 infection remains unclear. We previously demonstrated that the viral reservoir was…”
Get full text
Journal Article -
14
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Published in Nature medicine (01-03-2010)“…The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine development. Antigens derived from natural HIV-1 sequences have elicited only…”
Get full text
Journal Article -
15
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
Published in Nature communications (05-03-2021)“…The establishment of a long-lived viral reservoir is the key obstacle for achieving an HIV-1 cure. However, the anatomic, virologic, and immunologic features…”
Get full text
Journal Article -
16
Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
Published in Journal of Virology (01-10-2012)“…OA Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+…”
Get full text
Journal Article -
17
Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D
Published in Journal of Virology (01-05-2007)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
18
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1
Published in PloS one (14-11-2018)“…Live, attenuated viral vectors that express HIV-1 antigens are being investigated as an approach to generating durable immune responses against HIV-1 in…”
Get full text
Journal Article -
19
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
Published in Nature communications (27-10-2020)“…Viral rebound following antiretroviral therapy (ART) discontinuation in HIV-1-infected individuals is believed to originate from a small pool of CD4+ T cells…”
Get full text
Journal Article -
20
Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo
Published in PLoS pathogens (01-12-2019)“…Adenoviral vectors have shown significant promise as vaccine delivery vectors due to their ability to elicit both innate and adaptive immune responses…”
Get full text
Journal Article